Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. Augmenix, Inc., a medical technology company that develops, ...
Prostate cancer is currently one of the most common cancers in the UK; more than 40,000 cases are diagnosed each year. Typical treatment plans include a high dose of radiotherapy that aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results